Hemel Hempstead, UK – The first SPECTRALIS OCT2 Module, the next generation OCT from Heidelberg Engineering, has been delivered at Southampton General Hospital.
Just released, the much in demand upgrade provides a platform for advanced applications such as OCT angiography*.
“The imaging team and the consultants are all very excited about the new investment we made for the Eye Unit”, explains Gabriella De Salvo, Consultant Ophthalmologist at University Hospital Southampton. “We decided to invest in the SPECTRALIS OCT2 because we believe it is an excellent tool that will allow us to improve the quality of both our patient care and service. We trust that its high resolution and fast acquisition speed will have a huge impact on the number of patients we see in our outpatient clinics and will allow us to increase our capacity.”
“We have always believed in multimodality imaging and are eager to experience the latest diagnostic capabilities, such as 55° widefield MultiColor and BluePeak fundus autofluorescence”, continues Gabriella. “These new imaging modalities will enable us to be even more precise in the diagnosis and follow-up of various retinal and glaucomatous diseases, and to better study those conditions affecting the mid and peripheral retina. We value and find very useful the three-dimensional view of the retina visualised in the transverse image, and we are looking forward to seeing the release of the SPECTRALIS OCT Angiography Module*, which will certainly be the ‘cherry on the top’ of this marvellous diagnostic tool.”
The OCT2 Module brings the next generation of OCT technology to the SPECTRALIS diagnostic imaging platform. It combines a high scan rate of 85,000 Hz with Heidelberg Engineering’s proprietary TruTrack Active Eye Tracking to provide excellent image quality and significantly improved acquisition speed.
*The OCT Angiography Module for SPECTRALIS is under development and not currently for sale.